Overpriced: Trump Wipes $24.6 Bln Off Drug and Biotech Stocks in 20 Minutes

President-elect Donald Trump speaks during a rally at the Giant Center, Thursday, Dec. 15, 2016, in Hershey, Pa.

During his press conference on Wednesday, the US President-elect Donald Trump said US medicines are made overseas and are too expensive, and proper bidding could help lower the costs, provoking a selloff in big pharma and biotech stocks.

 ___________

Sputnik: US big pharma suffered a major hit during Wednesday’s press conference of the President-elect Donald Trump, who blasted drugmakers for making their product overseas and subsequently importing it, and vowed to introduce proper bidding procedures in order to curb drug prices and “save billions.”

Biotech and drugmaker stocks slumped in the immediate aftermath of these remarks, reflecting the market perception of the big pharma as artificially overpriced. Pharmaceutical and biotech equities crashed on Wednesday after President-elect Donald Trump blasted the “big pharma” lobbying practices as artificially driving prices and supporting vicious foreign trade patterns.

“They’re getting away with murder,” Trump said. “Pharma has a lot of lobbyists and a lot of power and there is very little bidding. We’re the largest buyer of drugs in the world and yet we don’t bid properly and we’re going to save billions of dollars.”

The US government, Trump said, is paying much more for medicines than the open market price would be, therefore, transparent bidding is vital in order to counter the powerful pharma lobbies. Subsequently, the market sentiment shifted toward expectations of lower biotech and drug industry premiums down the road, resulting in a selloff in related stocks.

“Our drug industry has been disastrous, they’re leaving left and right,” Trump said. “They supply our drugs but they don”t make them here, to a large extent.” Obamacare, Trump said, must be repealed and replaced “essentially simultaneously.”

The iShares Nasdaq Biotech exchange-traded fund (ETF) plunged 4pc in its biggest one-day decline in three months. S&P Pharmaceuticals, Biotechnology & Life Sciences Index dipped 1.7pc

“When the president-elect says we’re going to negotiate drug pricing, you have to take that seriously, but at the same this is a complicated issue because there’s not going to be clarity on drug pricing reform anytime soon,” Brad Loncar of the Loncar Cancer Immunotherapy ETF said. “When somebody that high profile says something that negative, people do not want to invest in it.”

Initially, when Trump was still a candidate for the US presidency, he was perceived as pharma industry champion, and his most recent remarks align him with Congress Democrats in a way, who, however, tend to favour tougher administrative regulation rather than proper and transparent competitive bidding.
Trump might have become disgruntled with select industries doing business with the US government most recently because of high costs of their services to US taxpayers, and President-elect is committed to cut the expenses of the federal government as part of his fiscal strategy.

During the 20 minutes of Trump’s press conference, big pharma lost some $24.6 bln out of its aggregate market value of $906.8 bln.

In particular, equities of Celgene dropped 3.5pc on Wednesday afternoon; Johnson & Johnson retreated 1.61pc; Bristol-Myers dropped 5.5pc; Pfizer declined by 2.75pc; Amgen slid 2.27pc; AbbVie lost 4.2pc; Gilead shed 2.3pc; and Eli Lilly tumbled 2.6pc.

Shares of the Kenilworth, NJ-based Merck & Co., Inc were surprisingly up 1.67pc because of the news of the Food and Drug Administration having decided to speed up their review of Merck’s proposed lung-cancer medicine.

This March 1, 2014 file photo shows part of the website for HealthCare.gov, seen in Washington. President Barack Obama’s health care law has become a tale of two Americas. States that fully embraced the law’s coverage expansion are experiencing a significant drop in the share of their residents who remain uninsured, according to an extensive new poll released Tuesday. States whose leaders still object to “Obamacare” are seeing much less change.
Previously, Trump criticised defence enterprises for overcharging the US government, including the highly publicised story focusing on Air Force One, dubbed by Trump as “too expensive.” During the press conference on Wednesday, Trump mentioned Lockheed Martin, Ford, and United Technologies amongst the companies whose business practices are harmful to the US economic interests, mainly, in the form of consumer goods being produced overseas and subsequently imported into the US.

The drug industry, on its part, has greatly benefitted from the Obamacare reform, which attracted more funds out of Americans’ pockets into the sphere of medical services. The bloated budget spending of the past eight years has also resulted in significant redistribution of wealth towards the well-connected Washington lobbies, with pharma being among the biggest.

Despite his critical stance on the issue of drug prices, and the cautious support from the Democrats, including the now-again-independent Bernie Sanders, Trump is still seen by big pharma as good news. The S&P Biotech Index is still 9pc above its election day level.

“We look forward to working with the new administration and Congress to advance proactive, practical solutions to improve the marketplace and make it more responsive to the needs of patients,” Stephen Ubl of Washington-based Pharmaceutical Research and Manufacturers of America (PhRMA) said.

___________

Share...Share on FacebookShare on Google+Tweet about this on TwitterEmail this to someoneShare on LinkedInShare on RedditShare on Tumblr

Related Posts:



All content herein is owned by author exclusively. Some content may be satirical in nature. Expressed opinions are NOT necessarily the views of VT, VT authors, affiliates, advertisers, sponsors, partners, technicians or Veterans Today Network and its assigns. In addition, all images within are full responsibility of author and NOT Veterans Today Network.
Legal Notice - Comment Policy

Posted by on January 12, 2017, With 2391 Reads Filed under Government & Politics. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.

Comments Closed

8 Responses to "Overpriced: Trump Wipes $24.6 Bln Off Drug and Biotech Stocks in 20 Minutes"

  1. stonehillady  January 12, 2017 at 2:52 pm

    Who allowed Big Pharma to advertise on TV, their advertising budget could pay the debt of some of our smaller states. It’s outrageous what Americans put up with when it comes to false advertising, after when most of these drugs side effects, which they do claim, is organ failure and death. They should ban advertising like they did tobacco and most booze. Stop the advertising, since when do you tell your Dr., hey look, I saw this drug on TV, can I try it ? These Big Pharma Companies are worse then drug pushers on some sleazy downtown corner. End the ads, lower the prices, let the Dr.’s decide, what they want to prescribe.

  2. tonto  January 12, 2017 at 1:43 pm

    This is very good news…

  3. JohnZ  January 12, 2017 at 1:13 pm

    Pig Pharma actually pays people to drum up phony illnesses and diseases using abbreviations to scare people into buying their dangerous drugs.
    The FDA, completely corrupted by pig pharma has signed off on many of these worthless drugs, many of them cause more harm than good.
    It’s all about profit, profit, profit. Meanwhile America has the most expensive healthcare system in the world while producing the least results.
    Time for a reboot.
    As for the loss of pharma shares on Wall St.? who gives a crap!

  4. Andrew_Bukanov(Russia)  January 12, 2017 at 12:51 pm

    +

  5. Peter Johnson  January 12, 2017 at 11:56 am

    You people over there should nationalise your health service.

    When I lived in the US our health insurance (Blue Cross Blue Shield) was 160p a month for a family of five — two young healthy adults and three healthy little kids. No-one needed anything on a regular basis.

    Here in England the healthcare is F.R.E.E. and is far far far beyond Blue Cross Blue Shield in the US.

    It also costs about a third of the thenper capita healthcare in the US where many people have no health care and others have to make sure they don’t take any risks with their employment because they need the health benefits

  6. wjabbe  January 12, 2017 at 11:09 am

    Most real estate in New York is also overpriced too. You hardly read about the cheapest piece of junk there for less than $1 million. Who in their right mind would pay millions of dollars to buy a condo in a tall building like Trump Tower? Image if a fire broke out. How would you escape? Why they do not even put exterior stairs for fire escapes on these dangerous fire traps any more do they? I don’t care how carefully they are constructed, electrical or other types of fires can happen and most furnishings are quite flammable and give off horrible fumes too. Many of the windows do not even open. The higher up you are the harder it is to get down in an emergency. I bet most of these owners do not even have a plan of escape should a fire break out. When I travel I only stay at motels in a ground floor room. Even then you could die in a fire. New York is a price inflated cesspool fire trap. Just think of what would happen if real estate prices there dropped to what most people can afford? What would the poor rich elitist snobs do for money?

  7. joetv  January 12, 2017 at 10:48 am

    Any super large short sale positions cashed?

  8. joetv  January 12, 2017 at 10:47 am

    The totally fabricated Zika threat was promoted and, used to extort how much R&D money from the US tax payer$? Oh, don’t forget to get your flu shot.

You must be logged in to post a comment Login


TOP 50 READ ARTICLES THIS MONTH
From Veterans Today Network